| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.005 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.005 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |